This combination is indicated as a complete regimen for the treatment of human immunodeficiency virus (HIV-1) infection. It is prescribed for adults and pediatric patients weighing at least 40 kg. The regimen works as a full treatment and does not need to be combined with other antiretroviral drugs in most cases. It helps reduce viral load, improve immune function, and slow disease progression when taken consistently.

This combination works through a multi-targeted approach against HIV. Lamivudine and tenofovir disoproxil fumarate are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) that block the reverse transcriptase enzyme, preventing the virus from copying its genetic material. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that binds directly to the same enzyme, further inhibiting its activity. Together, these drugs effectively stop HIV from replicating, reducing viral load and helping the immune system recover.

This medication is available as a fixed-dose, film-coated tablet containing 600 mg efavirenz, 300 mg lamivudine, and 300 mg tenofovir disoproxil fumarate. The usual recommended dosage is one tablet taken once daily, preferably at bedtime. Taking it at night may help reduce certain side effects such as dizziness or vivid dreams. Patients should follow their doctor’s instructions carefully and maintain consistent daily dosing to ensure effective viral suppression.

Common side effects of this combination include dizziness, headache, nausea, diarrhea, tiredness, muscle pain, and difficulty sleeping. Some patients may experience abnormal dreams, impaired concentration, rash, or mood changes such as depression. More serious side effects, although less common, include bone loss, kidney problems, worsening of hepatitis B infection, and immune reconstitution syndrome. Patients should report any unusual symptoms, especially severe rash, allergic reactions, or psychiatric symptoms, to their healthcare provider promptly.

This medication should not be used in patients with known hypersensitivity to efavirenz, lamivudine, or tenofovir disoproxil fumarate. Caution is required in patients with a history of pancreatitis, liver disease, kidney problems, seizures, or bone disorders. Regular monitoring of blood counts, kidney function, liver parameters, and bone health is recommended during treatment. Women of childbearing potential should use effective contraception, as this regimen is not recommended during early pregnancy. Breastfeeding is generally avoided due to the risk of HIV transmission. Patients should also avoid driving or operating machinery if they experience dizziness or fatigue.

The combination of lamivudine, tenofovir disoproxil fumarate, and efavirenz offers a convenient and effective once-daily treatment option for HIV infection. By combining three powerful antiretroviral agents into a single tablet, it simplifies therapy and improves adherence. While it is generally effective and well tolerated, careful monitoring and regular follow-up are essential to manage side effects and ensure long-term success. With proper use, this regimen plays a vital role in modern HIV care.

It is used as a complete treatment regimen for HIV-1 infection in adults and children weighing at least 40 kg, helping to control the virus and improve immune function.

It works by blocking the reverse transcriptase enzyme through multiple mechanisms, preventing HIV from multiplying in the body.

It should be taken once daily as a single tablet, preferably at bedtime, to improve tolerance and reduce side effects.

Common side effects include dizziness, headache, nausea, diarrhea, fatigue, sleep disturbances, and abnormal dreams. These are usually manageable but should be monitored.

Yes, serious side effects may include kidney problems, bone loss, liver issues, worsening hepatitis B, and mental health changes such as depression or suicidal thoughts, which require immediate medical attention.

You should avoid taking other HIV medications unless prescribed, and inform your doctor about any other drugs or supplements to prevent interactions.

If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue your regular schedule. Do not take a double dose.

It should not be taken by patients with hypersensitivity to any of its components or those with certain medical conditions without proper medical supervision.